- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
NVO
Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News
There's a major pharmaceutical market deal afoot -- and it's worth over $1 billion -- so FMTX stock is heading higher on the news.
Hold Novo Nordisk Shares for Consistent International Growth
The company's value chain may have been shaken by Covid-19 but it wasn't broken, so Novo Nordisk stock holders should stay invested.
Novo Nordisk Suing Mylan Over Generic Victoza Drug
News of Novo Nordisk suing Mylan is spreading as the two companies prepare for a legal battle over a generic version of Victoza.